Aerocrine, a medical device company, provides devices like NIOX MINO and NIOX VERO, which measure fractional exhaled nitric oxide (FeNO), a biomarker for airway inflammation. These instruments are used by thousands of physicians and nurses in hospitals and asthma clinics around the globe to identify asthma and monitor patients’ progress in controlling the disease.
But what happens when environmental factors disturb these sensitive devices? Unfortunately, it can sometimes interrupt the ability to conduct measurements. “Occasionally, our instruments suffer performance issues from dry weather or humidity, and we have to replace them,” says Mats Carlson, Vice President of Global Business Development, Aerocrine. “That leads to a few days of downtime, when patients are not being monitored. We needed insight into these issues, so we could avoid that downtime.”